英国修订噻螨酮与茚虫威最大残留限量,2027年1月正式生效

世界农化网中文网报道:近日,英国健康与安全执行局(HSE)发布公告,对噻螨酮(hexythiazox)和茚虫威(indoxacarb)两种农药活性成分在部分农产品中的最大残留限量(MRLs)进行了修订。新限量已于2026年7月25日正式通过,并将于2027年1月25日起生效执行,以便贸易伙伴和食品经营者有时间适应新的限量标准。

Heidelberg Pharma deepens ADC alliance with Huadong

Why it matters: The companies plan to combine their technologies and development capabilities, including Heidelberg Pharma’s proprietary ATAC technology, which uses amanitin as a payload, with Huadong’s research and development capabilities.

Notch Signaling Switch Enables Scalable Helper T Cell Production for CAR T

A new Stem Cell Reports study describes a scalable method for generating CD4+ helper T cells from induced pluripotent stem cells (iPSCs). The work, which was done by scientists at Boston University’s Center for Regenerative Medicine (CReM) and Boston Medical Center, could boost efforts to generate off-the-shelf CAR T-cell therapies for use in patients with cancers and chronic inflammatory diseases. Their paper is aptly titled “ Generation of effector CD4+ T cells from human iPSC .”

CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial

Immunotherapies, like CAR T-cell therapy, are well known in the cancer field. But they can also be used to treat autoimmune disorders. Now, six patients with severe rheumatoid arthritis (RA) have received this treatment at Charité—Universitätsmedizin Berlin. The results from the world’s first clinical trial showed that disease activity decreased substantially in all participants. By the end of the observation period, three of the patients no longer required any medication for their RA.

EU-Backed Startup Develops Superior Cultivated Meat Inputs That Could Benefit GLP-1 Users

Can the cultivated meat industry benefit people on weight-loss drugs?One company is attempting to do just that. ProFuse Technology, a supplier of cell culture media supplements, spent two years working on a project to solve the cost, scalability and functional challenges of cultivated meat, backed by €2.4M ($2.8M) in funding from the European Innovation Council (EIC).

英国修订噻螨酮与茚虫威最大残留限量,2027年1月正式生效

大农化网报道:近日,英国健康与安全执行局(HSE)发布公告,对噻螨酮(hexythiazox)和茚虫威(indoxacarb)两种农药活性成分在部分农产品中的最大残留限量(MRLs)进行了修订。新限量已于2026年7月25日正式通过,并将于…

利尔化学上半年营收48.16亿元,核心产品量价助涨营收、汇兑损失吞噬利润

大农化网报道:8月28日,利尔化学股份有限公司(简称″利尔化学″)披露2026年半年度报告。 报告期内,公司实现营业收入481,594.66万元,同比增长6.86%;归属于上市公司股东的净利润24,953.09万元,同比减少7.77%;归属…

先正达2026H1营收122亿美元,异噁唑虫酰胺、氟唑菌酰羟胺等创新产品市场表现强劲

大农化网报道:全球营收规模最大的农业科技企业先正达集团公布2026年上半年及第二季度财务业绩,整体表现稳健,各业务单元盈利能力和利润率均有提升。集团持续战略性聚焦核心业务、深化创新布局并巩固人工智能(AI)领域的领先优势,同时严格管控成本,…

破解巴西制剂”修罗场”:差异化研发策略与创新路径,如何决胜全球最严苛田间市场?

大农化网报道: 巴西,全球农化制剂真正的″试金石″。热带高温、多变水质、复杂桶混、减量施药……极端且多变的田间环境,让众多在实验室表现优异的配方纷纷折戟。在巴西,制剂失败从来不是偶然,而是研发逻辑与田间现实脱节的必然结果。如何在这片全球最复…

欧盟成立RNA / 肽类生物农药风险评估研究中心,6000万丹麦克朗注资

随着基于RNA和多肽的生物技术农药在全球多国陆续获批上市,其对环境和公众健康的潜在影响仍缺乏充分研究。为此,丹麦哥本哈根大学牵头成立了一个全新的研究中心——ENSAFE,系统评估这类新型农药的生态风险,并帮助欧盟建立更高效的监管框架。 该中…